These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [How to evaluate the iron therapy]. Li R Zhonghua Nei Ke Za Zhi; 1996 Feb; 35(2):78-9. PubMed ID: 9275621 [No Abstract] [Full Text] [Related]
3. Should intravenous iron be upfront therapy for iron deficiency anemia? Auerbach M Pediatr Blood Cancer; 2011 Apr; 56(4):511-2. PubMed ID: 21298731 [No Abstract] [Full Text] [Related]
4. Maintaining iron balance with total-dose infusion of intravenous iron dextran. Case G ANNA J; 1998 Feb; 25(1):65-8. PubMed ID: 9543911 [TBL] [Abstract][Full Text] [Related]
5. Clinical update: intravenous iron for anaemia. Auerbach M; Ballard H; Glaspy J Lancet; 2007 May; 369(9572):1502-1504. PubMed ID: 17482969 [No Abstract] [Full Text] [Related]
6. The Use of Parenteral Iron Therapy for the Treatment of Postpartum Anemia. Nash CM; Allen VM J Obstet Gynaecol Can; 2015 May; 37(5):439-442. PubMed ID: 26168105 [TBL] [Abstract][Full Text] [Related]
7. Stability of iron dextran (DexFerrum) in peritoneal dialysis bags. Manley HJ; Grabe DW; Bailie GR; Norcross ML Perit Dial Int; 1998; 18(5):538-40. PubMed ID: 9848638 [No Abstract] [Full Text] [Related]
8. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. Plummer ES; Crary SE; McCavit TL; Buchanan GR Pediatr Blood Cancer; 2013 Nov; 60(11):1747-52. PubMed ID: 23832487 [TBL] [Abstract][Full Text] [Related]
9. Accelerated total dose infusion of low molecular weight iron dextran is safe and efficacious in chronic kidney disease patients. Sinha S; Chiu D; Peebles G; Swoboda P; Kolakkat S; Lamerton E; Fenwick S; Bhandari S; Kalra PA QJM; 2011 Mar; 104(3):221-30. PubMed ID: 20956457 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of iron deficiency by a bolus intravenous iron dextran in peritoneal dialysis]. Ficheux M; Cuny P; Lecouf A; Ryckelynck JP; Hurault de Ligny B; Lobbedez T Nephrol Ther; 2011 Dec; 7(7):558-61. PubMed ID: 21715234 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia. Reddy CM; Kathula SK; Ali SA; Bekal R; Walsh M Int J Clin Pract; 2008 Mar; 62(3):413-5. PubMed ID: 18005041 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary edema: atypical anaphylactoid reaction to intravenous iron dextran. Freter S; Davidman M; Lipman M; Bercovitch D Am J Nephrol; 1997; 17(5):477-9. PubMed ID: 9382172 [TBL] [Abstract][Full Text] [Related]
13. Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia. Dossabhoy NR; Turley S; Gascoyne R; Tapolyai M; Sulaiman K Ren Fail; 2014 Aug; 36(7):1033-7. PubMed ID: 24845687 [TBL] [Abstract][Full Text] [Related]
14. Use of intravenous iron supplementation in chronic kidney disease: an update. Macdougall IC; Geisser P Iran J Kidney Dis; 2013 Jan; 7(1):9-22. PubMed ID: 23314137 [TBL] [Abstract][Full Text] [Related]
15. Clinical perspective: iron replacement therapy in chronic heart failure. Cowie MR; Lucas R Int J Clin Pract; 2011 Jun; 65(6):645-8. PubMed ID: 21564435 [No Abstract] [Full Text] [Related]
17. The safety of intravenous iron dextran (Dexferrum) during hemodialysis in patients with end stage renal disease. Hood SA; O'Brien M; Higgins R Nephrol Nurs J; 2000 Feb; 27(1):41-2. PubMed ID: 10852689 [TBL] [Abstract][Full Text] [Related]
18. Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK. Pollock RF; Muduma G Expert Opin Drug Deliv; 2017 Dec; 14(12):1439-1446. PubMed ID: 29032713 [TBL] [Abstract][Full Text] [Related]